Cargando…
Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report
BACKGROUND: Bevacizumab is an antiangiogenic agent, and that synergizes with chemotherapeutic drugs. When used in combination therapies, Bevacizumab is associated with adverse events such as hemorrhage, gastrointestinal perforation, delayed wound healing, and pneumothorax. However, the molecular mec...
Autores principales: | Ozaki, Yuri, Yoshimura, Akiyo, Sawaki, Masataka, Hattori, Masaya, Gondo, Naomi, Kotani, Haruru, Adachi, Yayoi, Kataoka, Ayumi, Sugino, Kayoko, Horisawa, Nanae, Endo, Yuka, Nozawa, Kazuki, Sakamoto, Shoko, Iwata, Hiroji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407928/ https://www.ncbi.nlm.nih.gov/pubmed/32821655 http://dx.doi.org/10.5306/wjco.v11.i7.504 |
Ejemplares similares
-
A case of radiation-associated angiosarcoma after breast cancer
por: Horisawa, Nanae, et al.
Publicado: (2018) -
Amyloid tumor of the breast
por: Mori, Makiko, et al.
Publicado: (2019) -
A case of giant cell tumor of the breast, clinically suspected as malignant breast tumor
por: Terada, Mitsuo, et al.
Publicado: (2019) -
The significance of biopsy scar excision at the time of skin- or nipple-sparing mastectomy with immediate breast reconstruction
por: Ozaki, Yuri, et al.
Publicado: (2021) -
Evaluation of the Role of Axillary Lymph Node Fine-Needle Aspiration Cytology in Early Breast Cancer With or Without Neoadjuvant Chemotherapy
por: Takatsuka, Daiki, et al.
Publicado: (2023)